Lyell Immunopharma Inc
(LYEL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,424 | 125,650 | 145,647 | 286,214 | 224,372 |
| Marketable Securities | 357,695 | 400,650 | 400,576 | 289,217 | 371,376 |
| TOTAL | $499,824 | $534,165 | $554,686 | $586,854 | $606,410 |
| Non-Current Assets | |||||
| PPE Net | 93,096 | 97,836 | 102,654 | 108,096 | 113,677 |
| Investments And Advances | 19,000 | 19,000 | 48,507 | 54,730 | 68,953 |
| Other Non-Current Assets | 42,222 | 43,219 | 44,182 | 45,309 | 46,314 |
| TOTAL | $154,318 | $160,055 | $195,343 | $208,135 | $228,944 |
| Total Assets | $654,142 | $694,220 | $750,029 | $794,989 | $835,354 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,199 | 4,895 | 4,817 | 4,365 | 5,805 |
| Accrued Expenses | 25,670 | 24,914 | 28,126 | 29,652 | 24,832 |
| Other current liabilities | 1,010 | 2,544 | 1,576 | 1,047 | 3,753 |
| TOTAL | $30,879 | $32,353 | $34,519 | $35,064 | $34,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 56,762 | 58,710 | 60,558 | 62,352 | 64,109 |
| TOTAL | $56,762 | $58,710 | $60,558 | $62,352 | $64,109 |
| Total Liabilities | $87,641 | $91,063 | $95,077 | $97,416 | $98,499 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,800 | 12,747 | 12,705 | 12,593 | 12,551 |
| Common Shares | 26 | 25 | 25 | 25 | 25 |
| Retained earnings | -1,108,588 | -1,062,779 | -1,002,112 | -949,182 | -898,329 |
| Other shareholders' equity | -397 | -404 | -94 | -1,181 | -2,379 |
| TOTAL | $566,501 | $603,157 | $654,952 | $697,573 | $736,855 |
| Total Liabilities And Equity | $654,142 | $694,220 | $750,029 | $794,989 | $835,354 |